-
Aug 2, 2024 | 
jdsupra.com | Timothy Burroughs |John R Ingrassia |David Munkittrick
U.S. antitrust regulators, particularly the Federal Trade Commission, have been stepping up scrutiny of private equity investments in healthcare.
-
Jul 31, 2024 | 
law360.com | Timothy Burroughs |David Munkittrick |John R Ingrassia
By Timothy Burroughs, David Munkittrick and John Ingrassia (July 31, 2024, 4:16 PM EDT) -- This article is part of a monthly column that considers the significance of recent Federal Trade Commission announcements about antitrust issues. In this installment, we discuss the agency's increased scrutiny of private equity investments in healthcare. ... Law360 is on it, so you are, too.
-
May 24, 2024 | 
mondaq.com | John R Ingrassia |Timothy Burroughs |Whitney Magee Phelps |Precious Penny
The U.S. Department of Justice ("DOJ") recently announced the creation of the Health Care
Monopolies and Collusion Task Force (the "HCMC Task
Force") aimed at resolving antitrust issues in the health care
industry. Specifically, the HCMC Task Force will focus on
investigating issues related to the quality of patient care,
consolidations between health care entities, labor and employment,
and access and misuse of data.
-
May 23, 2024 | 
jdsupra.com | Timothy Burroughs |John R Ingrassia |Precious Penny
The U.S. Department of Justice (“DOJ”) recently announced the creation of the Health Care Monopolies and Collusion Task Force (the “HCMC Task Force”) aimed at resolving antitrust issues in the health care industry. Specifically, the HCMC Task Force will focus on investigating issues related to the quality of patient care, consolidations between health care entities, labor and employment, and access and misuse of data.
-
Apr 11, 2024 | 
jdsupra.com | Timothy Burroughs |John R Ingrassia
The Federal Trade Commission's Bureau of Competition and the U.S. Department of Justice Antitrust Division earlier this year released a joint statement reiterating document preservation obligations for companies and individuals that are the subject of government investigations or pending claims, highlighting ephemeral messaging platforms, such as Slack and Google Chats, that automatically delete communications, sometimes by default.[1] Both agencies announced updated language used in their...
-
Mar 19, 2024 | 
mondaq.com | Timothy Burroughs
The Federal Trade Commission's Bureau of Competition and the
Department of Justice Antitrust Division released a joint statement reiterating document
preservation obligations for companies and individuals that are the
subject of government investigations and litigations, emphasizing
messaging platforms, such as Slack and Google Chats, that
automatically delete communications.
-
Mar 11, 2024 | 
lexology.com | Timothy Burroughs
The Federal Trade Commission’s Bureau of Competition and the Department of Justice Antitrust Division released a joint statement reiterating document preservation obligations for companies and individuals that are the subject of government investigations and litigations, emphasizing messaging platforms, such as Slack and Google Chats, that automatically delete communications.
-
Feb 1, 2024 | 
mondaq.com | John R Ingrassia |Timothy Burroughs |Precious Penny
The Federal Trade Commission has announced revisions to HSR Act
and Clayton Act Section 8 thresholds, which are indexed annually in
alignment with prior year economic activity. As is our annual
practice, this alert identifies the adjustments that are likely to
be the most relevant to our clients and reiterates several
important practice tips.
-
Jan 30, 2024 | 
jdsupra.com | Timothy Burroughs |John R Ingrassia |Precious Penny
The Federal Trade Commission has announced revisions to HSR Act and Clayton Act Section 8 thresholds, which are indexed annually in alignment with prior year economic activity. As is our annual practice, this alert identifies the adjustments that are likely to be the most relevant to our clients and reiterates several important practice tips.
-
Jan 29, 2024 | 
lexblog.com | John R Ingrassia |Timothy Burroughs
John is a partner at the Firm, advising on the full range of foreign investment and antitrust matters across industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services consumer goods and health care. He is the first call clients make in matters relating to competition and antitrust, CFIUS or foreign investment issues.
